Immunohistochemistry for identification ofCCND1,NSD2, andMAFgene rearrangements in plasma cell myeloma
Immunohistochemistry for identification ofCCND1,NSD2, andMAFgene rearrangements in plasma cell myeloma
复制标题
免疫组织化学鉴定浆细胞骨髓瘤中 CCND1、NSD2 和 MAF 基因重排
DOI:
10.1111/cas.14109
复制
发表时间:
2019
期刊:
影响因子:
5.7
通讯作者:
Inagaki Hiroshi
中科院分区:
文献类型:
--
作者:
Murase Takayuki;Ri Masaki;Narita Tomoko;Fujii Keiichiro;Masaki Ayako;Iida Shinsuke;Inagaki Hiroshi
The t(11;14)/CCND1‐IGH, t(4;14)/NSD2(MMSET)‐IGH, and t(14;16)/IGH‐MAFgene rearrangements detected by fluorescence in situ hybridization (FISH) are used for risk stratification in patients with multiple myeloma (MM). Compared with conventional FISH techniques using fresh cells, immunohistochemistry (IHC) is much more cost‐ and time‐efficient, and can be readily applied to routinely prepared formalin‐fixed, paraffin‐embedded (FFPE) materials. In this study, we performed tissue FISH and IHC employing FFPE specimens, and examined the usefulness of IHC as a tool for detectingCCND1,NSD2, andMAFgene rearrangements. CD138 signals were used to identify plasma cells in tissue FISH and IHC analyses. With cohort 1 (n = 70), we performed tissue FISH and subsequently IHC, and determined IHC cut‐off points. In this cohort, the sensitivity and specificity for the 3 molecules were ≥.90 and ≥.96, respectively. With cohort 2, using MM cases with an unknown gene status (n = 120), we performed IHC, and the gene status was estimated using the cut‐off points determined with cohort 1. The subsequent FISH analysis showed that the sensitivity and specificity for the 3 molecules were ≥.92 and ≥.98, respectively.CCND1, NSD2, andMAFgene rearrangements were estimated accurately by IHC, suggesting that conventional FISH assays can be replaced by IHC.